Open Access iconOpen Access

REVIEW

The Potential of Circular RNAs as Biomarkers in Pulmonary Arterial Hypertension Related to Congenital Heart Disease

Fajri Marindra Siregar1,2, Sofia Mubarika Haryana3, Dyah Wulan Anggrahini4, Lucia Kris Dinarti4, Anggoro Budi Hartopo4,*

1 Doctorate Program of Medical and Health Science, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, 55281, Indonesia
2 Department of Biochemistry, Faculty of Medicine, Universitas Riau, Pekanbaru, 28133, Indonesia
3 Department of Histology and Cell Biology, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, 55281, Indonesia
4 Department of Cardiology and Vascular Medicine, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada Dr. Sardjito Hospital, Yogyakarta, 55281, Indonesia

* Corresponding Author: Anggoro Budi Hartopo. Email: email

Congenital Heart Disease 2024, 19(4), 375-388. https://doi.org/10.32604/chd.2024.054742

Abstract

A particular type of endogenous noncoding RNAs known as circular RNAs (circRNAs) has now become possible biomarkers for several diseases because of their stability and tissue-specific expression patterns. CircRNAs might play a role in various of biological processes. The identification of particular circRNAs dysregulated in pulmonary arterial hypertension (PAH) raises the possibility of these molecules serving as biomarkers for the disease’s early diagnosis and treatment. This review mainly summarizes the role and potential of circRNA as a future biomarker in PAH related to congenital heart disease. This study presented several potential circRNA targets as diagnostic biomarkers for PAH, discussed their biological functions, and addressed the challenges that need to be considered for their application in clinical settings.

Graphic Abstract

The Potential of Circular RNAs as Biomarkers in Pulmonary Arterial Hypertension Related to Congenital Heart Disease

Keywords


Cite This Article

APA Style
Siregar, F.M., Haryana, S.M., Anggrahini, D.W., Dinarti, L.K., Hartopo, A.B. (2024). The potential of circular rnas as biomarkers in pulmonary arterial hypertension related to congenital heart disease. Congenital Heart Disease, 19(4), 375-388. https://doi.org/10.32604/chd.2024.054742
Vancouver Style
Siregar FM, Haryana SM, Anggrahini DW, Dinarti LK, Hartopo AB. The potential of circular rnas as biomarkers in pulmonary arterial hypertension related to congenital heart disease. Congeni Heart Dis. 2024;19(4):375-388 https://doi.org/10.32604/chd.2024.054742
IEEE Style
F.M. Siregar, S.M. Haryana, D.W. Anggrahini, L.K. Dinarti, and A.B. Hartopo, “The Potential of Circular RNAs as Biomarkers in Pulmonary Arterial Hypertension Related to Congenital Heart Disease,” Congeni. Heart Dis., vol. 19, no. 4, pp. 375-388, 2024. https://doi.org/10.32604/chd.2024.054742



cc Copyright © 2024 The Author(s). Published by Tech Science Press.
This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
  • 284

    View

  • 109

    Download

  • 0

    Like

Share Link